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ABSTRACT

ARTICLE HISTORY

Viral infections are often studied in model mammalian organisms under specific pathogen-free
conditions. However, in nature, coinfections are common, and infection with one organism can
alter host susceptibility to infection with another. Helminth parasites share a long coevolutionary
history with mammalian hosts and have shaped host physiology, metabolism, immunity, and the
composition of the microbiome. Published studies suggest that helminth infection can either be
beneficial or detrimental during viral infection. Here, we discuss coinfection studies in mouse
models and use them to define key determinants that impact outcomes, including the type of
antiviral immunity, the tissue tropism of both the helminth and the virus, and the timing of viral
infection in relation to the helminth lifecycle. We also explore the current mechanistic under
standing of how helminth-virus coinfection impacts host immunity and viral pathogenesis. While
much attention has been placed on the impact of the gut bacterial microbiome on immunity to
infection, we suggest that enteric helminths, as a part of the eukaryotic macrobiome, also represent
an important modulator of disease pathogenesis and severity following virus infection.
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Introduction

Almost all mammalian species are inhabited by one or
more helminths.1 The earliest record of helminth
infection in humans is found in mummified indivi
duals dating back thousands of years as well as in
ancient medical writings.2,3 Earlier, helminth infec
tions were widespread in the tropics and subtropics,
and it is only in the last century that many industria
lized nations have become largely helminth-free due
to access to clean water and improved sanitation and
hygiene practices.4 Since helminths share a long coe
volutionary history with humans, their eradication is
thought to have caused changes to host physiology,
metabolism, and immunity, and explained a rise in
allergic and inflammatory diseases.5 Notwithstanding
these points, a quarter of the world’s population
remains infected by helminths, making helminth
coinfection a major modulator of host susceptibility
to infectious diseases.6,7 Indeed, given the substantial
geographical overlap between helminth-endemic
areas and the prevalence of prominent infectious dis
eases including malaria, tuberculosis, human
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immunodeficiency virus (HIV), and hepatitis
C virus, it is possible that helminths alter host suscept
ibility to many pathogenic microorganisms.8–10
Helminths that commonly infect humans estab
lish patency in the gastrointestinal tract (GI) tract
and are collectively known as GI helminths or
enteric helminths.6,11 GI helminths include
Ascaris lumbricoides (A. lumbricoides), Trichuris
trichiura (T. trichiura), Necator americanus
(N. americanus), and Ancylostoma duodenale
(A. duodenale), which collectively infect more
than two billion people worldwide.6 Some of these
helminths enter their host via skin penetration in
the form of infective larvae, whereas others enter
via the fecal-oral route in the form of embryonated
eggs or infective larvae usually through consump
tion of contaminated water. Inside the host, GI
helminths undergo developmental molts to gener
ate mature adult larvae that establish infection in
the GI tract. Some GI helminths also traverse
through other organs such as the lungs before
establishing patency in the GI tract.6 In addition
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to GI helminths, the parasitic flatworm Schistosoma
is also a major public health concern as it infects
over 250 million individuals worldwide every year,
mostly in the tropical regions.11 Schistosoma spp.
have a complex life cycle where they invade multi
ple tissues including the lungs and the liver, before
establishing chronicity in the portal vein and
depositing their eggs into the lumen of the GI
tract.12 Intestinal helminth infections are rarely
lethal, but often cause morbidity in immunocom
promised individuals and children including intest
inal bleeding, iron deficiency, and protein
malnutrition.6,13–15 However, in most infected
individuals, the worm burden is low with no signs
of overt clinical disease.6 This is in part due to the
adaptation of helminths to their mammalian hosts
and their utilization of immune evasion strategies
that enable them to persist with limited tissue
damage.16 Moreover, the host develops tolerance
as a strategy to prevent the adverse effects of hel
minth-mediated or immune-mediated tissue
damage.17 Such commensal-like adaptation,
although mutually beneficial to helminths and
host could inform host responses to subsequent
interactions with heterologous pathogens such as
viruses.
Although considerable field studies have been
performed to determine the effect of helminth
infection status on susceptibility to heterologous
pathogens including viruses, there is limited
mechanistic insight as to how these interactions
affect outcomes. In this review, we discuss different
scenarios in which enteric helminth coinfections
have been reported to be beneficial or detrimental
during viral infections. Using coinfection studies in
mouse models, we discuss known molecular
mechanisms involved in helminth–virus interac
tions and propose three main determinants that
influence this interaction. Finally, we raise out
standing questions in the field of helminth-virus
coinfection that could lead to future studies.

Beneficial outcomes
Enteric helminths and respiratory viruses

Enteric helminth coinfections can be beneficial
against diseases caused by respiratory viruses.
While in some cases lung disease is directly caused

by respiratory viruses, in other situations morbidity
is associated with excess infiltration of immune
cells in the lungs that compromises pulmonary
mechanics and gas exchange.18 One mechanism
by which enteric helminths confer benefits against
disease pathogenesis caused by respiratory viruses
is by mitigating lung immunopathology. Limiting
the infiltration of immune cells to the lungs or
changing the quality of the immune response can
lessen pulmonary inflammation and improve sur
vival. Using mouse models, the impact of helminth
coinfection on some respiratory viruses has been
examined. The murine helminth Heligmosomoides
polygyrus bakeri (H. polygyrus; previously called
Nematospiroides dubius) is widely utilized as
a model of human GI hookworm infection. Early
studies showed that coinfection of mice with
H. polygyrus and influenza virus decreased the
lung consolidation caused by influenza virus
infection.19,20 Although the mechanisms underly
ing these changes were not fully addressed, the
investigators speculated that this might be due to
the immunosuppressive effect of H. polygyrus.
Alternatively, the observed protection against pul
monary disease might be due to reduced infiltration
of inflammatory immune cells into the lungs.
Corroborating evidence for this latter explanation
came from a study showing that enteric helminth
infection modulates the trafficking patterns of
immune cells such that their numbers increase in
local lymphoid tissues (e.g., mesenteric lymph
nodes) and decrease in peripheral lymphoid
tissues.21 Consequently, activation of immune
cells in peripheral lymphoid tissues and their
migration to extraintestinal tissue compartments
such as the lungs was reduced. This effect was also
seen during coinfection of mice with the enteric
helminth Trichinella spiralis (T. spiralis) and influ
enza virus, with reduced infiltration of neutrophils,
natural killer (NK) cells, and T cells in the lungs of
coinfected mice.22 In theory, altered trafficking of
immune cells could also affect the accumulation of
protective immune cells in the lungs and compro
mise antiviral immunity leading to increased viral
burden. However, despite mounting suboptimal
virus-specific CD8+ T cell response in the lungs
and draining lymph nodes of coinfected mice,21,23
coinfection with H. polygyrus or T. spiralis resulted
in only minor changes in viral burden, which
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suggests that a few protective virus-specific CD8+
T cells are sufficient for influenza virus clearance in
the lungs.
Helminth infection induces type 2 immune
responses characterized by upregulation of specific
cytokines including IL-4, IL-5, IL-9, and IL-13.24
These cytokines polarize different immune cells
such as CD4+ T helper 2 (TH2) cells and alterna
tively activated macrophages (AAMs) or M2
macrophages.24 Although CD8+ T cells are not
directly involved in anti-helminth immunity, type
2 cytokines elicited during helminth infection can
cause bystander activation of naïve CD8+ T cells.
These activated CD44+CD8+ T cells resemble vir
tual memory T cells (TVM cells) that are implicated
in protection against viral infections.25,26 In
a recent study, TVM-like CD8+ T cells induced by
systemic administration of Schistosoma mansoni
(S. mansoni) eggs were shown to boost antiviral
CD8+ T cell responses and protect mice against
intranasal murine gammaherpesvirus (MHV)-68
infection.27 Similarly, coinfection with S. mansoni
cercariae protected mice against the influenza virus
strain PR8 and the paramyxovirus, the pneumonia
virus in mice (PVM), a model of human respiratory
syncytial virus (RSV).28 Although S. mansoniinduced mucus production in lung airways was
implicated in conferring nonspecific protection to
respiratory virus infection, induction of TVM-like
CD8+ T cells might have an antiviral role against
these respiratory viruses, which warrants further
evaluation. Moreover, the accumulation of TVMlike CD8+ T cells is common during other helminth
infections, including H. polygyrus, although
whether they contribute to the protective effects
seen during H. polygyrus and influenza virus coin
fection remains unexplored. Moreover, during
instances where helminth coinfection results in
the systemic dissemination of gut commensal bac
teria, TVM-CD8+ T cells might provide protection
against systemic bacterial infection.29,30
In addition to type 2 immune responses, hel
minths induce an anti-inflammatory or regulatory
response characterized by induction of Foxp3+ reg
ulatory CD4+ T cells (Tregs) that suppress inflam
mation via production of cytokines such as IL-10,
IL-35 and TGF-β.31 The induction of Tregs is
thought to aid in the persistence of some helminth
parasites in the host by impeding protective TH2
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responses.32,33 However, in some settings, such as
H. polygyrus infection, an early Treg response was
reported to prevent immunopathology in mice sug
gesting that Tregs may be involved in multiple
aspects of helminth–host interactions.34,35
Although helminth-induced Tregs are implicated
in preventing autoimmunity and inflammation in
mice,31,36,37 whether they suppress immunopathol
ogy caused by viral infections is not clear. It is
conceivable that Treg induction due to helminth
coinfection could suppress hyperinflammatory or
inappropriate immune responses often associated
with respiratory viral infections.18
Another mechanism by which helminths pro
tect against respiratory viral infection is via
induction of the type I interferon (IFN) response.
Although helminths are generally not associated
with the direct induction of type I IFNs,
H. polygyrus infection was shown to upregulate
type I IFNs in the lungs and protect mice against
RSV.38 Unexpectedly, the protective effects of
H. polygyrus were intact even in mice lacking
type 2 cytokine signaling (IL-4Rα−/-) or adaptive
immunity (RAG1−/-) but were lost in mice lack
ing type I IFN signaling (IFNAR1−/-). How
H. polygyrus infection induces type I IFN in the
lungs was not elucidated in this study. However,
protective benefits were lost in germ-free mice,
indicating a dependence on the commensal
microbiota. Whether this effect occurs through
systemic translocation of gut bacteria/products
or via commensal bacteria/intestinal epithelial/
immune cell crosstalk warrants experimental test
ing. It is intriguing to speculate that enteric hel
minths, via changes in the composition of
commensal bacteria, could impact tonic IFN sig
naling that provides resistance to local and sys
temic viral infections.39–41 More specifically, type
I IFN signaling in conventional dendritic cells
was shown to support TH2 induction in response
to S. mansoni egg antigen.42 Hence, tonic IFN
signaling could enhance dendritic cell migratory
activities and thereby affect immunity to viral
infections. Alternatively, the type I IFN response
could induce regulatory B cells that protect
against immunopathology.43 Thus, through
diverse potential mechanisms, enteric helminths
can confer host resistance against respiratory viral
infections and disease pathogenesis (Table 1).
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Table 1. Murine models that examine the impact of helminth coinfection on respiratory viruses.
Respiratory
virus

Helminth

Helminth target
tissue

Influenza virus
S-15

Ascaris Suum

Gut, liver, lungs

Influenza virus Nippostrongylus
A2/Japan/170
brasiliensis

Influenza virus Heligmosomoides
A2/Japan/170
polygyrus bakeri

Influenza virus Heligmosomoides
A2/Japan/170
polygyrus bakeri

Influenza virus
X31

Trichinella spiralis

Influenza virus
X31

Trichinella spiralis

Influenza virus
A/Puerto
Rico/8/34

Heligmosomoides
polygyrus bakeri

Timing of virus coinfection and
Outcome compared to virus-only
mice

Varying days post helminth infection (0, 2,
4, 6, 8, 10, 12, 16).
Coinfected mice had higher mortality
(90%) compared to virus alone (30%)
when virus infected at day 8 post
helminth infection. However, mortality
started decreasing when mice were
infected prior to day 8 or later.
Skin, lungs, gut
Day 0 (same day) and day 14 post
helminth infection.
Day 0: Coinfected mice had higher
mortality (26%) compared to virus alone
(6%). Lung consolidation score in
coinfected mice (41%) was higher
compared to virus alone (26%).
Day 14: Similar mortality rates (8%) and
lung consolidation scores (26%)
between coinfected and virus alone
infected mice.
Gut
Day 0 (same day) and day 14 post
helminth infection.
Lung consolidation score in coinfected
mice (17%) was lower compared to
virus alone (23%) when virus infected
at day 14 post helminth infection but no
change at day 0.
Gut
Day 14 post helminth infection.
Lung consolidation score in coinfected
mice (22%) was lower compared to
virus alone (38%). Coinfected mice
showed 100-fold lower viral titer
compared to virus alone. Antibody titer
against the virus was 2-fold lower in
coinfected mice compared to virus
alone.
Gut, skeletal muscle
Day 7 and day 60 post helminth infection.
Day 7: Coinfected mice showed 100%
weight gain by day 8 compared to virus
alone (85%); similar viral titers.
Day 60: No differences between virus
alone and coinfected mice.
Gut, skeletal muscle
Day 12 post helminth infection.
Coinfected mice had 3-fold reduced
virus-specific CD8+ T cells compared to
virus-alone; similar viral titers.
Gut
Day 14 post helminth infection.
Coinfected mice had less than 2-fold
increase in viral load compared to virusalone; coinfected mice had 2-fold
reduced virus-specific CD8+ T cells
compared to virus-alone.
Lungs, liver, blood, gut 10–12 weeks post helminth infection.
Coinfected mice had lower mortality
(20%) compared to virus alone (100%);
coinfected mice also displayed reduced
weight loss compared to virus alone.

Influenza virus Schistosoma
A/Puerto
mansoni (Omani
Rico/8/34 and
human isolate)
Pneumonia
virus of mice
clone 15
Pneumonia
Schistosoma
Lungs, liver, blood, gut 12 weeks post helminth infection.
virus of mice
mansoni (Omani
Coinfected mice displayed reduced
clone 15
human isolate)
weight loss compared to virus alone;
coinfected mice also had reduced viral
load compared to virus-alone.
Respiratory
Heligmosomoides Gut
Day 10 post helminth infection.
syncytial virus
polygyrus bakeri
Coinfected mice displayed reduced
strain A2
weight loss compared to virus alone.
Murid
Schistosoma
Lungs, liver, blood, gut Day 22 post S. mansoni infection or day 6
herpesvirus 4
mansoni,
post N. brasiliensis infection.
strain MHVNippostrongylus
Coinfected mice displayed reduced
68
brasiliensis
weight loss compared to virus alone;
coinfected mice had 100-fold reduced
viral load compared to virus-alone.

Mechanism

Reference

Unknown

Nayak et al., 196544

Unknown

Wescott et al., 196620

Unknown

Wescott et al., 196620

Unknown

Chowaniec et al.,
197219

Unknown

Furze et al., 200622

Unknown

Osborne et al., 201423

Unknown; likely due to King et al., 201421
altered immune cell
trafficking.

Unknown; type I IFNindependent; likely
due to TNFαdependent goblet
cell hyperplasia

Scheer et al., 201428

Unknown

Scheer et al., 201428

Type I IFN- dependent; McFarlane et al.,
microbiome201738
dependent
Bystander activated
Rolot et al., 201927
CD8+ T cells (TVM);
CD8+ T cell intrinsic
IL-4 signal
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Detrimental outcomes
Enteric helminths and enteric viruses

Enteric helminths alter the GI tract tissue micro
environment including the epithelium lining the
gut lumen as well as the immune cells residing in
the underlying stroma.24 For example, helminthinduced type 2 cytokines such as IL-4 and IL-13
instruct macrophages to adopt a regulatory pheno
type to promote repair of tissue damage caused by
helminths.45,46 These IL-4-induced STAT6dependent AAMs contrast with classically activated
M1 macrophages with a pro-inflammatory pheno
type. Effector molecules such as arginase-1 and
RELM-α produced by AAMs regulate the synthesis
of collagen constituents involved in the rebuilding
of damaged tissue.46–48 Additionally, AAMs can
suppress an unrestrained pathological immune
response thereby preventing inflammation and tis
sue fibrosis.49,50 Some studies also have suggested
that AAMs, together with other immune cells such
as neutrophils, can kill or expel helminth larvae
directly.51–53 These helminth-induced AAMs may
be one of the cell types driving impaired host
immune responses to other microbes including
Salmonella typhimurium, Citrobacter rodentium,
and Mycobacterium tuberculosis, and enteric
viruses.23,54–57 In one study, the coinfection of
mice with T. spiralis or H. polygyrus and murine
norovirus (MNoV) resulted in enhanced viral repli
cation in the GI tract.23 Specifically, Ym1,
a chitinase-like molecule expressed by AAMs,
impaired the proliferation of virus-specific CD8+
T cells, which resulted in a failure to clear the
MNoV infection from the GI tract.
Another mechanism by which helminths could
impact enteric viral infection is by modulating or
expanding the specific cell types that viruses target.
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In the MNoV study, although a defect in AAMmediated priming of virus-specific CD8+ T cells
was implicated in enhanced viral burden, AAMs
induced in vitro supported higher replication of
MNoV.23 The possible skewing of AAMs by IL-4
compromises their innate antiviral functions,
enabling viruses to replicate within them. Indeed,
AAMs are less efficient than conventional macro
phages in their ability to phagocytose antigens and
kill engulfed pathogens.45 Helminth infection also
results in the expansion of specific intestinal epithe
lial lineages including tuft cells and goblet cells,
which have roles in the detection and clearance of
luminal worms through a “weep and sweep”
response.58,59 Coinfection of helminths and enteric
viruses that have tropism for these specific cell
types might result in greater numbers of susceptible
target cells and increased viral infection. Notably,
the MNoV strain CR6, which has tropism for tuft
cells and shows higher levels of shedding following
a coinfection with T. spiralis or during treatment
with IL-4 complexes (IL-4 c).23,60 Similarly, coin
fection with H. polygyrus enhanced murine astro
virus (muAstV) infection and shedding in the GI
tract possibly due to an increased number of
infected goblet cells, a target of muAstV.61 Thus,
enteric helminth coinfection could be detrimental
to the host by enhancing infection and transmis
sion of some enteric viral infections (Table 2).
Whether enteric helminth coinfection also
enhances host susceptibility to other enteric viruses
(e.g., rotavirus and enteroviruses) remains to be
determined.
Enteric helminths and systemic viruses

Upon infection of the primary tissue, some viruses
disseminate systemically and infect multiple

Table 2. Murine models that examine the impact of helminth coinfection on enteric viruses.
Virus

Helminth

Helminth
Target
tissue

Timing of virus coinfection and Outcome
compared to virus-only mice

Murine norovirus strain Trichinella spiralis,
CW3 (acute) and
Heligmosomoides
CR6 (persistent)
polygyrus bakeri

Gut, skeletal
muscle

Murine astrovirus

Gut

Day 12 post helminth infection.
STAT6Osborne
Coinfected mice had 100-fold increased viral load
dependent
et al.,
compared to virus-alone; coinfected mice had 5-fold AAMs
201423
+
reduced virus-specific CD8 T cells compared to virusalone.
Day 12 post helminth infection.
Unknown;
Ingle et al.,
Coinfected mice had 10-fold increase in viral load
likely due to
202162
compared to virus-alone.
increase in
goblet cells

Heligmosomoides
polygyrus bakeri

Mechanism

Reference
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organs. For example, flaviviruses such as West Nile
virus (WNV), which are principally transmitted
into the skin by mosquitoes, can disseminate to
the brain and spinal cord after initial local
replication.63 WNV can also spread to other organs
including the GI tract, where it preferentially
infects enteric neurons resulting in intestinal
dysmotility.64 A recent study showed that
H. polygyrus coinfection in mice exacerbated the
disease caused by multiple neurotropic flaviviruses
that infect the GI tract including WNV, Zika virus,
and Powassan virus.65 Specifically, H. polygyrus
modulated WNV infection and outcome via a tuft
cell-IL-4 mediated axis, such that enteric neurons
became more susceptible to WNV, resulting in
disruption of the neuronal network and greater
intestinal dysmotility. These phenotypes were asso
ciated with barrier function defects in the small
intestine, translocation of gut commensal bacteria,
systemic dissemination of bacteria, and disruption
of the architecture in lymphoid tissues that resulted
in a collapse of WNV-specific CD8+ T cell
responses and elevated viral burden in the central
nervous system. In this study, IL-4 alone (no
H. polygyrus infection) was sufficient for these
effects, as these phenotypes were recapitulated by
IL-4 c treatment of mice prior to WNV infection.65
Thus, enteric helminths can enhance susceptibility
to systemic viral infections that also have tropism
for the GI tract. The coinfection phenotype was
dependent on the expression of the receptor IL-4α
on intestinal epithelial cells, suggesting that the type
2 response induced by helminths was mediated
through the intestinal epithelium.65 In comparison,
IL-4 c treatment did not alter CD8+ T cell responses
or gut pathology after infection with the Armstrong
strain of the lymphocytic choriomeningitis virus
(LCMV), likely because this virus does not infect
the GI tract.65
Helminths can affect the pathogenesis of other
systemic viruses such as MHV-68 and the WE
strain of LCMV.66 In one study, when MHV-68infected mice were coinfected with either
S. mansoni eggs or H. polygyrus larvae via oral
gavage, MHV-68 reactivated from latency.67 IL4 c treatment alone was not sufficient to induce
MHV-68 reactivation but required a combination
of IL-4 c and anti-IFN-γ suggesting that a ‘twosignal’ mechanism is needed for the reactivation

of latent herpesvirus following helminth coinfec
tion. Consistent with this idea, the coinfection
with S. mansoni and LCMV results in reduced
expression of type I IFN, namely IFN-β, and its
downstream interferon stimulated genes (ISGs) in
the liver.68 The results showed that coinfected mice
had elevated viral burden, severe hepatotoxicity,
and higher mortality compared to mice infected
with LCMV alone. However, how helminthinduced immune responses alter IFN-β levels and
which aspects of type 2 immunity was involved in
this process was not addressed. Of note, the type 2
cytokines such as IL-4, IL-5, IL-10 and IL-13 were
reduced in coinfected mice when compared to
S. mansoni-infected mice suggesting a reciprocal
effect of LCMV on anti-helminth immune
responses.68 S. mansoni infection also impaired
immune responses against systemic infection with
vaccinia virus resulting in enhanced viral burden
(Table 3).69 Thus, helminths can impair host
immune responses to viral infections through
local or systemic effects.
Helminths traversing the lungs and respiratory
viruses

Some human helminths such as A. lumbricoides,
A. duodenale, and N. americanus have an extrain
testinal phase in which the larvae migrate through
different tissues such as the lungs before reaching
the GI tract. As a surrogate to examine the effects of
such helminths on viral infection, Ascaris suum
(A. suum) and Nippostrongylus brasiliensis
(N. brasiliensis) are used as models in mice. An
earlier study found that coinfection of mice with
A. suum and influenza virus resulted in adverse
clinical outcomes.71 In comparison to mice infected
with influenza virus alone that caused 30% mortal
ity, coinfection resulted in 90% mortality.
Moreover, the coinfected mice also died sooner
than mice infected with influenza alone (5 versus
7 days) and showed pronounced dyspnea. Similar
observations were made when mice were coinfected
with N. brasiliensis and influenza virus.20
Coinfected mice showed higher mortality (26% vs.
6%) and greater lung consolidation scores (41% vs.
26%) compared to mice infected with the influenza
virus alone. These findings suggest that
a connection with helminths that traverse through
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Table 3. Murine models that examine the impact of helminth coinfection on systemic viruses.
Virus

Helminth

Helminth
target
tissue

Timing of virus coinfection and Mechanism
Outcome compared to virusonly mice

Recombinant Vaccinia
virus

Schistosoma mansoni

Lungs, liver,
blood, gut

Lymphocytic
choriomeningitis virus

Schistosoma mansoni
(Puerto Rican strain)

Lungs, liver,
blood, gut

Murine
gammaherpesvirus-68

Schistosoma mansoni eggs, Lungs, liver,
Heligmosomoides
blood, gut,
polygyrus bakeri, IL-4 c
systemic
+ anti-IFN-γ
Ascaris columnaris
Gut, brain
(Baylisascaris procyonis)

7 weeks post helminth infection. Unknown
Actor et al., 199369
Coinfected mice had increased
viral load compared to virusalone; coinfected mice showed
impaired CD8+ T cell
functionality compared to virusalone.
10 weeks post helminth infection. Unknown
Edwards et al., 200568
Coinfected mice had higher
mortality (80%) compared to
virus alone (0%); coinfected
mice had 100-fold increased
viral load compared to virusalone.
Day 42 prior to helminth infection.STAT6-dependent; two Reese et al., 201467
Coinfection resulted in latent
signal model: IL-4
virus reactivation.
and anti-IFN-γ

Colorado tick fever virus
and Eastern
encephalitis virus (EEV)
West Nile virus (WNV),
Powassan virus and
Zika virus

Heligmosomoides polygyrus Gut
bakeri

Reference

Day 0 (same day).
Unknown;
Clark et al., 196970
Coinfected mice had higher
likely due to
(100%) mortality compared to
impaired blood
EEV alone (68%).
brain barrier
Day 12 post helminth infection. STAT6 dependent; IL- Desai et al., 202165
Coinfected mice had higher
4Rα expression on
mortality (75%) compared to
intestinal epithelium
WNV alone (15%).

the lungs and respiratory viruses can be detrimental
to the host. However, the precise mechanism by
which these lung-traversing helminths impact the
pathogenesis of respiratory viruses and disease out
comes has not been elucidated.

Enteric helminths and sexually transmitted viruses

In a recent study, coinfection of mice with
N. brasiliensis was shown to exacerbate intrava
ginal Herpes simplex virus-2 (HSV-2) mediated
epithelial ulceration in the female genital tract
(FGT).72 N. brasiliensis infection alone was
shown to induce recruitment of eosinophils to
the FGT. However, following HSV-2 coinfec
tion of the vaginal epithelium, local

eosinophilia was enhanced, which caused
damage to the virally infected vaginal epithe
lium. This immunopathological exacerbation
occurred independently of IL-4Rα and instead
depended on an IL-33/IL-5/eosinophil axis.72
Thus, a helminth infection that alters systemic
immunity and affects the milieu of distant tis
sues, despite not actively colonizing those tis
sues, can also worsen the outcome of local viral
infections (Table 4).

Determinants of coinfection outcomes

Helminth coinfection can have either a positive or
negative impact on host resistance to viral infec
tion. Although coinfections occur commonly in the

Table 4. Murine models that examine the impact of helminth coinfection on sexually transmitted viruses.
Virus

Helminth

Helminth target
tissue

Timing of virus coinfection Mechanism
Outcome compared to
virus-only mice

Reference

Herpes simplex virus-2

Nippostrongylus
brasiliensis

Lungs, gut

Day 7 post helminth infection. IL-33/IL-5/eosinophil
Coinfected mice had vaginal axis
epithelial ulceration. No
change in viral load
compared to virus-alone.

Chetty et al., 202172
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real world, they are complicated to dissect as many
factors can potentially influence coinfection out
come. For instance, helminth infection itself is
a complex process whereby the larvae pass through
different stages of their life cycle, partly inside the
host and partly in the environment.6,73,74
Moreover, some helminths traverse through differ
ent tissues in the body and evoke a wide array of
innate and adaptive immune cells.16 Furthermore,
helminths can be expelled from the host or occupy
a niche such as the GI tract and persist for long
periods.75 Coinfection of the host with a virus that
already harbors helminth parasites further adds to
this complexity, as viruses may infect more than
one tissue, have unique cellular tropism and can be
acute, persistent, or latent. Moreover, helminth and
virus can have both local and systemic effects on
host immunity that can act in concert or oppose
one another.24,41 Although the coinfection outcome
is determined by the unique combination of hel
minth and virus, there are a few common factors
that might influence whether the coinfection out
come is beneficial or detrimental. For example,
what type of immune response does the helminth
provoke (i.e., a protective or pathological immune
response to virus infection)? Where does the hel
minth reside (i.e., in the same or different tissues
relative to the virus)? And when does virus infec
tion happen in relation to the life cycle of the
helminth (i.e., during the acute or chronic stage of
the helminth)? These three interrelated themes
have been framed in the following sections as deter
minants of coinfection outcomes, namely 1) the
nature of the antiviral immune response, 2) the
tissue tropism of helminth and virus, and 3) the
timing of viral infection in relation to the helminth
life cycle.
The nature of the antiviral immune response is
a key element in determining the outcome because
helminths and viruses evoke disparate immune
responses, type 2 and type 1, respectively, that can
antagonize one another.76,77 When such contrasting
immune responses are elicited in the same host dur
ing helminth-virus coinfections, the upregulation of
one may suppress the other, which in turn can com
promise host defenses. This is evident where enteric
helminths cause defects in either innate or adaptive
immune responses against viruses (Tables 2 and
3).23,67,68 In the setting of helminth coinfection, if

antiviral immunity becomes attenuated, it could
compromise control of virus infection. However, if
the virus-induced immune response in infected tis
sues is pathological in nature and contributes to
disease, then the tempered immunity due to hel
minth infection might be beneficial. This is evident
during coinfections of enteric helminths and respira
tory viruses (Table 1).19,22 Alternatively, bystander
activation of immune cells such as CD8+ TVM cells
could have protective roles in antiviral immunity.27
Thus, the nature of the antiviral immune response is
a key determinant of the coinfection outcome.
Another theme emerging from helminth-virus
coinfection studies is that the tissue tropism of the
helminth and virus also affects outcome (Figure 1).
This is illustrated in infection studies of the lung
(Table 1). Enteric helminths alleviated respiratory
viral disease likely because they occupy a different
niche, gut versus lungs.22,38 However, influenza
virus infection in the setting of lung-penetrating
helminths such as A. suum and N. brasiliensis,
results in worsened pulmonary disease and higher
mortality rates.20,71 These examples support the
hypothesis that the tissue compartmentalization of
the helminth and the virus may determine coinfec
tion outcome (Figure 1). Indeed, when mice were
coinfected with enteric helminths and viruses tar
geting the GI tract such as MNoV and WNV, the
intestinal viral burden was increased.23,65 Similarly,
when mice infected with S. mansoni that penetrates
liver tissue were coinfected with LCMV,
a hepatotropic virus, local viral burden, and hepa
totoxicity were enhanced.68 Thus, when helminthvirus coinfection occurs in the same tissue (e.g.,
lungs, liver and GI tract), it can result in detrimen
tal outcomes.
The mechanisms underlying these detrimental
effects could be diverse. Overlapping tissue tropism
could compromise the induction of local immune
responses against viral infections as observed in the
enteric helminth and MNoV coinfection study.23 It
could also enhance local cellular targets of viral
infections as implicated in the enteric helminth
and muAstV coinfection study or induce changes
in viral cellular targets such as enteric neurons so
that they become more susceptible to infection with
WNV.62,65 It is also possible that helminth infection
may lead to systemic enhancement of cellular tar
gets and might increase viral replication not only at

GUT MICROBES

e1961202-9

Figure 1. Tissue tropism of helminths and viruses can modulate coinfection outcome. (Left) Helminths and viruses that infect the
same tissue can result in detrimental outcome for the host. For example, N. brasiliensis or A. suum and influenza infection of lungs;
S. mansoni/LCMV infection of the liver; T. spiralis/MNoV or H. polygyrus/MNoV infection of the small intestine. (Right) Helminth and virus
infection of different tissues can have beneficial effects. For example, helminths in their enteric phase such as H. polygyrus, T. spiralis
and S. mansoni protect against respiratory viruses including influenza, RSV and PVM. However, H. polygyrus coinfection with WNV in the
GI tract was detrimental to the host. The effect of enteric helminths on other systemic viruses that do not have tropism for the GI tract is
unknown.

the local site but also in distant tissues, as suggested
in the context of helminth-HIV coinfections where
the helminth-mediated expansion of CD4+ T cells
could
promote
HIV
replication
or
transmission.78,79 Another possibility is that coin
fection of the same tissue could exacerbate physical
damage to the tissue and thereby compromise its
integrity, which is likely the case during lungpenetrating helminths and respiratory virus coin
fection, and S. mansoni/LCMV coinfection that
results in damage to liver tissue.20,68,71,80
Beneficial effects are often seen when helminths
dwell in tissues other than ones that the virus
infects. This is evident in the case of the enteric
helminth H. polygyrus and respiratory viruses such
as influenza virus and RSV.19,38 However,
S. mansoni, despite its capacity to transiently

penetrate through the lungs, was shown to protect
against intranasal infection with influenza virus
strain PR8 and MHV-68.27,28 This can also be
attributed to the timing of virus inoculation in
relation to the helminth life cycle as observed in
earlier studies.20,71 In the case of the S. mansoni/
PR8 coinfection study, PR8 was administered dur
ing the chronic phase of S. mansoni (10–12 weeks
later), when S. mansoni is no longer is present in
the lungs but inhabits the portal veins and mainly
affects the liver tissue. Similarly, in S. mansoni- and
N. brasiliensis-mediated protection studies, MHV68 was inoculated at time points when these hel
minths were no longer were present in the lung
tissue.27 The effect of timing of virus inoculation
will be discussed in more detail below.
Alternatively, it is possible that the nature of
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antiviral immunity, such as a TVM CD8+ T cell
response, plays a dominant role in protection
despite having the same tissue niche of helminth
and virus. Consistent with this, coinfection of mice
with N. brasiliensis, a worm that does not colonize
the female genital tract (FGT), was shown to
exacerbate intravaginal HSV-2 induced immuno
pathology in the FGT.72 According to the hypoth
esis of different tissue niche, this combination of
helminth–virus interactions should have been ben
eficial. However, N. brasiliensis induced alterations
in systemic immunity causing a recruitment of
eosinophils to FGT regions, and upon viral infec
tion, local eosinophilia was enhanced causing
damage to virally infected epithelium.72 The nature
of antiviral immunity (immunopathological) in the
helminth/HSV-2 study played a dominant role over
tissue tropism and worsened outcomes. This study
highlights that the helminth-virus coinfection pro
cess is complex and indicates that in some instances
one particular determinant may play a dominant
role in determining the coinfection outcome.
Although not mutually exclusive with the idea of
tissue tropism, the timing of viral infection in rela
tion to the stage of helminth lifecycle or antihelminth immunity may also impact coinfection
outcomes (Figure 2a). Some helminths have an
extraintestinal phase, whereas others are confined

to the GI tract throughout their lifecycle. For exam
ple, N. brasiliensis and A. suum penetrate the lungs
before establishing infection in the GI tract. If
a virus infects a tissue during the time frame
when helminths are present in the same tissue, it
might have negative consequences in line with the
same tissue – detrimental outcome hypothesis.
However, if the virus infects a tissue that is no
longer occupied by helminths or if helminths have
passed through the tissue and occupy a different
tissue niche, the outcome might not be detrimental.
Additional evidence for this idea comes from
a study showing that when mice were orally
gavaged with eggs of A. suum, and 8 days later
inoculated with the swine influenza virus, mortality
was higher than in mice infected with the influenza
virus alone.80 After oral gavage, the peak penetra
tion period of A. suum in the lungs is around day 8,
and thereafter the number of larvae in the lungs
decline. However, when the influenza virus was
inoculated either a few days before or after, rather
than on day 8 after A. suum infection, mortality
rates were reduced. Hence, the negative effect of
A. suum and influenza virus was greatest when
A. suum larvae were present in the lungs in high
numbers. Analogous results were observed during
an N. brasiliensis and influenza virus coinfection
study (Figure 2a).20

Figure 2. Timing of viral infection with respect to the life cycle stage of the helminth affects coinfection outcome. (a) Infection
with influenza virus when N. brasiliensis is in the lungs (day 1–2) has a detrimental outcome, whereas infection with influenza at day 14,
when N. brasiliensis has been cleared, has no effect on the host. As seen with other enteric helminths such as T. spiralis and H. polygyrus,
whether infection of influenza virus during the enteric phase of N. brasiliensis has a beneficial effect is unknown. (b) Type 2 immune
responses to the enteric helminth H. polygyrus peak after one week of infection, plateau, and then decline as worm burden reduces.
During the peak phase, type 2 immune cells and cytokines are elevated, which can antagonize antiviral responses if virus infects during
this phase. However, when virus infection occurs earlier or later, when type 2 responses are still developing or have waned, the effect
on antiviral responses might be moderate, little, or none.
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The timing of viral infection also applies to coin
fections with beneficial outcomes. When mice were
infected with T. spiralis, and 7 days later infected with
the influenza virus, coinfected mice showed greater
weight recovery than animals infected with the influ
enza virus alone.22 However, when influenza was
administered 60 days following T. spiralis infection,
there was no change in weight recovery. This is
because, following oral gavage, T. spiralis larvae
have a peak enteric phase at day 7; the effect of
T. spiralis on immunomodulation is likely most pro
minent during the enteric phase. By day 60, the larvae
are encysted in skeletal muscles and may not have
immunomodulatory effects. Consistent with this idea,
in other studies that showed reduced lung immuno
pathology due to helminth-virus coinfections, the
respiratory virus was administered during the time
frame where helminths were in their enteric
phase.27,28,38 Thus, timing of viral infection may be
a key factor that determines the helminth-virus con
fection outcome.
The nature and magnitude of the type 2 immune
response changes as the helminths progress
through different life cycle stages. For example,
early during helminth infection, innate responses
are elevated, whereas adaptive TH2 responses occur
later.81 The innate responses differ in terms of their
role in helminth immunity during the early and late
stages. For example, early during H. polygyrus
infection, NK cells are involved in preventing
immunopathology, whereas in later stages they
may be dispensable or even assist TH2
responses.34,82,83 It is likely that viral coinfection
occurring early during helminth infection may
result in a different outcome compared to virus
infection at later time points. Furthermore, during
persistent H. polygyrus infection, the TH2 response
peaks in the mesenteric lymph nodes around 10–
14 days post-infection and then declines as the
parasite burden reduces. When the virus is inocu
lated at the peak of the TH2 response, the negative
effects on antiviral immunity may be greater than if
the virus was inoculated at later time points
(e.g., day 30+) (Figure 2b). One major factor that
may influence the quality of the immune response
to helminths is anti-helminth drugs or deworming
treatments. Deworming causes substantial altera
tions in immune signatures in infected individuals,
which might affect their response to subsequent
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heterologous pathogens.84–86 Consistent with this
idea, in a H. polygyrus/WNV coinfection study,
treatment of mice with an anti-helminthic prior to
virus infection prevented the exacerbated mortality
otherwise evident in untreated coinfected mice.65
However, in another setting involving the filarial
helminth Litomosoides sigmodontis, the suppressive
effects of the helminth on the quality and quantity
of neutralizing antibody responses to an influenza
vaccine lasted even after the helminth infection was
terminated.87 This was due to the impact of IL-10
producing Treg cells that were sustained in the host
after parasite clearance.87 Thus, the timing of virus
infection in relation to the helminth lifecycle may
or may not affect the outcome of coinfection.
Limitations and future directions

Studies addressing the effects of helminth coinfec
tions on viral pathogenesis are limited. Therefore, it
is difficult to draw definitive conclusions with the
few examples available. Moreover, the outcomes of
different coinfection studies can depend on the
unique nature of the helminth and the virus com
bination. Whether the consequences extend to
other viruses that infect via similar routes or occupy
similar tissue niches remains to be determined.
Although the beneficial effects of enteric helminths
in mitigating immunopathology caused by respira
tory viral infections have been observed in the
context of influenza, RSV, MHV-68 and PVM,
whether it applies to emerging viruses such as
SARS-CoV-2 is unknown.88–92 Unlike some
respiratory viruses that are confined to the lungs,
SARS-CoV-2 affects multiple organs including the
GI tract.93 Since the immune response and patho
genesis of SARS-CoV-2 is systemic, the outcome of
coinfection is difficult to predict.
Another limitation of current studies is the hel
minth dosing strategy used. In most experiments,
mice were gavaged with a bolus of helminth larvae
or eggs. However, in nature, helminths infections
mostly occur in a recurrent fashion that can be
mimicked by a ‘trickle dose’ infection design.94,95
Future experiments should evaluate the impact of
this type of helminth infection dosing on virus coin
fection. Moreover, in most studies, virus inoculation
is performed at a specific time point that corre
sponds to the onset of patency, peak egg burden, or
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elevated type 2 responses (e.g., day 12 post with
H. polygyrus). Since in the natural world, coinfec
tions with viruses can occur at any time during the
helminth lifecycle, it is important to include virus
inoculations at different time points to acquire
a broader picture of helminth-virus outcomes.
Consistent with this idea, infection of influenza
virus at varying days post-helminth infection
resulted in vastly different mortality rates in coin
fected mice.71 Host sex differences are another factor
influencing the severity of helminth infection both in
humans as well as in mice,96,97 yet coinfection studies
have not been assessed for sex-based differences.
Moreover, most studies examine the unidirectional
effect of helminths on antiviral responses. Whether
immune responses to viruses affect the helminth
lifecycle remains underexplored.
Helminths alter the commensal bacteria
diversity,98 and viral infections are affected by per
turbations in commensal bacteria.41 Thus, it is
likely that helminth-mediated changes to the
microbiome can affect viral pathogenesis.
However, only two studies have explored whether
helminth-virus outcomes depend on changes in the
microbiome.23,38 In one MNoV study, viral patho
genesis did not change when enteric helminth coin
fections were performed in germ-free mice
compared to conventionally caged mice, suggesting
that helminth-induced changes in MNoV patho
genesis occur independently of the microbiome.23
However, for RSV, germ-free mice did not recapi
tulate the beneficial effects of enteric helminth coin
fection in preventing RSV disease.38 Along with
commensal bacteria, enteric helminths have coha
bitated the GI tract of mammals throughout evolu
tion. Thus, their sudden reduction in certain parts
of the industrialized world due to deworming and
improved sanitation is likely to affect the host–
microbiota relationship.44 How these changes in
the community structure of the microbiota affect
host resistance to viral infections needs further
examination. Since parasitic helminth infections
in humans are often associated with
malnutrition,99 another area of future investigation
could be understanding how helminth-induced
changes in host metabolism100,101 affect viral patho
genesis and immunity. Whether helminth-induced
metabolic reprogramming compromises immune

responses to viral infection warrants further
exploration. Moreover, recently there has been
a growing interest in understanding the effects of
host microbial metabolites in influencing viral
pathogenesis,41,102,103 and helminths, via changes
in the microbiome, could regulate host responses
to viral infections. Future studies of helminth–virus
interactions will likely reveal additional determi
nants that influence coinfection outcomes as well
as uncover novel mechanisms through which hel
minth infection affects antiviral immunity.
Outstanding Questions
(1) In what other scenarios can enteric helminths benefit host resistance
against viral infection or be detrimental? Does the different tissue
tropism – beneficial outcome hypothesis apply to viruses that infect
mucosal surfaces such as the female reproductive tract (e.g., Herpes
simplex virus and Zika virus)? How do enteric helminths affect the
pathogenesis of respiratory viruses that disseminate into multiple
tissues (e.g., SARS-CoV-2)?
(2) Can helminth-virus coinfection studies reveal novel cross-talk between
different compartments in the mammalian host such as the intestinal
epithelium, enteric nervous system and systemic immunity or unravel
fundamental discoveries in the gut-brain or gut-lung axis?
(3) How do enteric helminth-mediated alterations in the commensal
bacteria mechanistically affect viral infections? Do helminths modu
late tonic type I IFN levels that prime antiviral immunity?
(4) What do helminth-virus coinfection studies inform us about the
‘hygiene hypothesis’ and can the use of anti-helminth drugs alter
host susceptibility to viral vaccines such as SARS-CoV-2 vaccines?
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